Results 271 to 280 of about 278,076 (329)
By integrating biomechanical and epigenetic cues, the evolutionarily conserved TPM1 super‐enhancer drives myogenesis via TEAD4‐mediated chromatin looping. This mechanism produces species‐specific outputs (linear TPM1 mRNA in mice and CircTPM1 in bovine) that activate PI3K/AKT mechanotransduction and the MYH10/MYL3 axis to execute cytoskeletal ...
Ruimen Zhang +27 more
wiley +1 more source
Compact bacterial recombination complexes drive efficient kilobase-scale knock-in in mammalian cells. [PDF]
Luo Y +12 more
europepmc +1 more source
Generating polyploid millet through CRISPR/Cas9-mediated editing of the <italic>SiOSD1</italic> gene [PDF]
Yuqing Liang +6 more
openalex +1 more source
A mutually exclusive screening system is established to identify negative regulators of highly plastic genes. Dual specificity phosphatase (DUSP9) is a novel negative regulatory molecule of PD‐L1 by dephosphorylating STAT3, and acts as a target molecule in combination with PD‐1 antibody for tumor immunotherapy and a new clinical biomarker for ...
Yuzhe Hu +9 more
wiley +1 more source
RECC: A Red/ET-CRISPR/Cas9-based system enabling genome mining of marine <i>Pseudoalteromonas</i> for novel natural products. [PDF]
Wang ZJ +5 more
europepmc +1 more source
HMGB2–RAD21 Axis Promotes Fibro/Adipogenic Progenitor Proliferation and Regulates Fat Infiltration
This study constructed the first developmental atlas of embryonic skeletal muscle fibro/adipogenic progenitors (FAPs) and identified an HMGB2+ FAPs subpopulation that regulates FAP pool size and muscle homeostasis. HMGB2 directly targets the RAD21 promoter, and its knockout significantly reduces FAP numbers, thereby lowering the potential for ...
Xian Tong +14 more
wiley +1 more source
AAV-mediated gene therapy for the CNS: The case for early treatment. [PDF]
Liebscher Vidal LE, Martinez-Navio JM.
europepmc +1 more source

